HK1044279B - 治療心血管疾病用的氨基四氫化萘衍生物 - Google Patents

治療心血管疾病用的氨基四氫化萘衍生物

Info

Publication number
HK1044279B
HK1044279B HK02105724.0A HK02105724A HK1044279B HK 1044279 B HK1044279 B HK 1044279B HK 02105724 A HK02105724 A HK 02105724A HK 1044279 B HK1044279 B HK 1044279B
Authority
HK
Hong Kong
Prior art keywords
therapy
cardiovascular diseases
aminotetralin
aminotetralin derivative
left ventricular
Prior art date
Application number
HK02105724.0A
Other languages
English (en)
Other versions
HK1044279A1 (en
Inventor
Bongrani Stefano
Razzetti Roberta
Civelli Maurizio
Umile Alberto
Chiesi Paolo
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/328,434 external-priority patent/US6103760A/en
Priority claimed from PCT/EP2000/005231 external-priority patent/WO2000076544A1/en
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of HK1044279A1 publication Critical patent/HK1044279A1/xx
Publication of HK1044279B publication Critical patent/HK1044279B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02105724.0A 1999-06-09 2002-08-06 治療心血管疾病用的氨基四氫化萘衍生物 HK1044279B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/328,434 US6103760A (en) 1995-03-17 1999-06-09 Aminotetralin derivative for the therapy of cardiovascular diseases
PCT/EP2000/005231 WO2000076544A1 (en) 1996-03-13 2000-06-07 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (2)

Publication Number Publication Date
HK1044279A1 HK1044279A1 (en) 2002-10-18
HK1044279B true HK1044279B (zh) 2004-01-16

Family

ID=23280968

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105724.0A HK1044279B (zh) 1999-06-09 2002-08-06 治療心血管疾病用的氨基四氫化萘衍生物

Country Status (27)

Country Link
US (2) US6576671B1 (zh)
EP (1) EP1183046B1 (zh)
JP (1) JP2003501483A (zh)
KR (1) KR20020005772A (zh)
CN (1) CN1354676A (zh)
AT (1) ATE248607T1 (zh)
AU (1) AU766230B2 (zh)
BR (1) BR0012121A (zh)
CA (1) CA2376715A1 (zh)
CZ (1) CZ20014406A3 (zh)
DE (1) DE60004996T2 (zh)
DK (1) DK1183046T3 (zh)
EA (1) EA003830B1 (zh)
EE (1) EE200100663A (zh)
ES (1) ES2206240T3 (zh)
HK (1) HK1044279B (zh)
HU (1) HUP0201650A2 (zh)
IL (1) IL146962A0 (zh)
MA (1) MA26796A1 (zh)
MX (1) MXPA01012638A (zh)
NO (1) NO20016000L (zh)
NZ (1) NZ515727A (zh)
PL (1) PL352119A1 (zh)
PT (1) PT1183046E (zh)
SK (1) SK18012001A3 (zh)
TR (1) TR200103526T2 (zh)
ZA (1) ZA200110091B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions
EP1500392A1 (en) * 2003-07-24 2005-01-26 CHIESI FARMACEUTICI S.p.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
IT1275935B1 (it) * 1995-03-17 1997-10-24 Chiesi Farma Spa Derivato di aminotetralina per la terapia di malattie cardiovascolari

Also Published As

Publication number Publication date
PL352119A1 (en) 2003-07-28
CZ20014406A3 (cs) 2002-04-17
ZA200110091B (en) 2002-12-09
EP1183046B1 (en) 2003-09-03
TR200103526T2 (tr) 2002-04-22
MXPA01012638A (es) 2002-07-22
SK18012001A3 (sk) 2002-04-04
JP2003501483A (ja) 2003-01-14
NO20016000L (no) 2002-02-11
DE60004996T2 (de) 2004-07-22
CN1354676A (zh) 2002-06-19
KR20020005772A (ko) 2002-01-17
NO20016000D0 (no) 2001-12-07
DE60004996D1 (de) 2003-10-09
EA003830B1 (ru) 2003-10-30
NZ515727A (en) 2003-06-30
BR0012121A (pt) 2002-05-14
PT1183046E (pt) 2003-12-31
HK1044279A1 (en) 2002-10-18
HUP0201650A2 (hu) 2002-12-28
EP1183046A1 (en) 2002-03-06
IL146962A0 (en) 2002-08-14
MA26796A1 (fr) 2004-12-20
ES2206240T3 (es) 2004-05-16
EE200100663A (et) 2003-04-15
ATE248607T1 (de) 2003-09-15
CA2376715A1 (en) 2000-12-21
AU5076500A (en) 2001-01-02
EA200101159A1 (ru) 2002-06-27
AU766230B2 (en) 2003-10-09
DK1183046T3 (da) 2004-01-05
US6576671B1 (en) 2003-06-10
US20030207944A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
DE60329001D1 (en) 8-hydroxychinolinderivate
BE2012C040I2 (zh)
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
WO2001001973A3 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
RU94045155A (ru) Способы ингибирования болезни альцгеймера
MY119375A (en) Treatment of tinnitus using neuroprotective agents
MXPA04003245A (es) Hidroxipropilaminas.
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
HK1130422A1 (zh) 去鐵酮的新用途
HK1034446A1 (en) Therapeutic agents.
ZA200110091B (en) Aminotetralin derivative for the therapy of cardiovascular diseases.
BG106209A (en) Therapeutic agents
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
EP1331004A3 (en) Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
YU59102A (sh) JEDINJENJA KORISNA ZA LEČENJE ILI PREVENCIJU OBOLJENJA U KOJEM UČESTVUJE ALFA-2β-ADRENOCEPTOR
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070607